公司跟踪报告 ・北交所 9 表2:分业务预测(百万元) 证券|CGS 根据公司招股说明书,公司主营业务按产品可分为检测业务、耗材销售和其他技术服务,其中 检测业务是公司的主要营收来源,2023年营收占比为85.10%。未来公司计划加强各业务板块市场 开拓力度和业务协同,持续提升公司市场占有率,通过募投项目建设,扩大检验检测业务、认证业 务、标准服务与耗材业务、计量业务等现有业务板块规模,做大做强主营业务。在此基础上,积极 推进并购项目,开辟多元化发展的新路径,有望实现公司整体运营规模高效跨越式增长。 1)检测业务:公司收入主要来源于检测业务,公司通过加强实验室能力建设以及数字化建设, 提升业务人员技术水平和实验室综合能力,积极提升检测能力,加大市场开拓力度,业务量和销售额 均有所增长。我们预测 2024-2026年检测业务的营业收入分别为1.65、1.68、1.70亿元,增长率分 别为 1.50%、1.76%、1.00%。 2) 耗材销售:公司积极开展国家标准样品研制工作,加大宣传力度,着重市场客户开发,耗材 销售业务收入有望保持平稳增长态势。我们预测 2024-2026 年耗材销售的营业收入分别为 912、 ...

一、权益分派方案 1、本公司 2023 年年度权益分派方案为： 以公司现有总股本 92,242,108 股为基数，向全体股东每 10 股派 1.799611 元 人民币现金。 2023 年年度权益分派实施公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 中纺标检验认证股份有限公司 2023 年年度权益分派方案已获 2024 年 5 月 21 日召开的股东大会审议通过，本次实施分配方案距离股东大会审议通过的时 间未超过两个月。 现将权益分派事宜公告如下： 本次权益分派基准日合并报表归属于母公司的未分配利润为 122,658,600.05 元，母公司未分配利润为 44,805,224.62 元。本次权益分派共计派发现金红利 16,599,991.22 元。 2、扣税说明 证券代码：873122 证券简称：中纺标 公告编号：2024-041 中纺标检验认证股份有限公司 （1）个人股东、投资基金适用股息红利差别化个人所得税政策,个人股东、 投资基金持股 1 个月（含 1 个月）以内，每 10 股补缴税款 0 ...

法律意见书 北京中银律师事务所 关于中纺标检验认证股份有限公司 □银律师事务所 ZHONG YIN LAW FIRM 北 FIT 关于中纺材 有限公司 1010524299 2023 年年度股东大会 之法律意见书 二〇二四年五月 地址: 北京市朝阳区光华路正大中心北塔 11-12 层 邮编： 100020 传真： 010-65876666-6 电话: 010-65876666 本所律师已经对公司提供的与本次股东大会有关的文件、资料进行审查判 断,并据此出具法律意见。 本所同意将本法律意见书随公司其他公告文件一并予以公告,并对法律意见 书中发表的法律意见承担责任。 本所律师按照律师行业公认的业务标准、道德规范及勤勉尽责精神,对公司 提供的文件和有关事实进行了核查和验证,现出具法律意见如下: 2 2023 年年度股东大会 之法律意见书 致:中纺标检验认证股份有限公司 北京中银律师事务所(以下简称"本所") 接受中纺标检验认证股份有限公 司(以下简称"公司")的委托,指派见证律师出席公司 2023年年度股东大会 (以下简称"本次股东大会")进行法律见证,并依据《中华人民共和国公司法》 (以下简称"《公司法》")《中 ...

证券代码：873122 证券简称：中纺标 公告编号：2024-040 中纺标检验认证股份有限公司 2023 年年度股东大会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2024 年 5 月 21 日 2.会议召开地点：公司会议室 3.会议召开方式：现场投票和网络投票相结合方式 4.会议召集人：董事会 5.会议主持人：董事长马咏梅女士 6.召开情况合法、合规、合章程性说明： 本次股东大会的召集、召开、议案审议及表决程序符合《公司法》等有关法 律、法规及《公司章程》的规定。 （二）会议出席情况 出席和授权出席本次股东大会的股东共 37 人，持有表决权的股份总数 76,534,638 股，占公司有表决权股份总数的 82.97%。 其中通过网络投票参与本次股东大会的股东共 36 人，持有表决权的股份总 数 22,534,638 股，占公司有表决权股份总数的 24.43%。 （三）公司董事、监事、高级管理人员出席或列席股东大会情况 1.公司 ...

证券代码：873122 证券简称：中纺标 公告编号：2024-039 中纺标检验认证股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 □特定对象调研 √业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 活动时间：2024年5月13日 ...

证券代码：873122 证券简称：中纺标 公告编号：2024-039 中纺标检验认证股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 □特定对象调研 √业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 活动时间：2024年5月13日 ...

证券代码：873122 证券简称：中纺标 公告编号：2024-038 中纺标检验认证股份有限公司 2023 年年度报告业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 说明会类型 中纺标检验认证股份有限公司（以下简称"公司"）于 2024 年 4 月 29 日在 北京证券交易所指定信息披露平台（www.bse.cn）披露了《2023 年年度报告》， 为方便广大投资者更深入了解公司 2023 年年度经营业绩的具体情况，加强与投 资者的互动交流，公司拟召开 2023 年年度报告业绩说明会。 二、 说明会召开的时间、地点 （一）会议召开时间：2024 年 5 月 13 日 15:00-17:00。 （二）会议召开地点 本次年报业绩说明会将采用网络远程的方式举行，投资者可登陆全景网"投 资者关系互动平台"（http://ir.p5w.net）参与本次年报业绩说明会。 三、 参加人员 公司董事长：马咏梅女士 公司董事、总经理：李斌先生 公司董事、财务总监、董事会秘书：牛艳花女士 公司保荐代 ...

Financial Performance - Operating revenue for the first quarter of 2024 was CNY 37,990,900.45, representing a year-on-year increase of 5.85%[12] - Net profit attributable to shareholders for the first quarter of 2024 was a loss of CNY 1,229,962.87, a decline of 261.11% compared to the same period last year[12] - The net profit for Q1 2024 was a loss of ¥1,561,559.61, compared to a profit of ¥9,348.59 in Q1 2023, indicating a substantial decline[37] - The company reported a total profit loss of ¥1,618,560.16 in Q1 2024, contrasting with a profit of ¥118,583.42 in Q1 2023[37] - Operating profit for Q1 2024 was a loss of ¥1,650,132.69, compared to a profit of ¥85,867.50 in Q1 2023[37] - The total comprehensive loss for Q1 2024 was ¥1,561,559.61, compared to a comprehensive income of ¥9,348.59 in Q1 2023[39] Cash Flow - The net cash flow from operating activities decreased by 33.60% year-on-year, amounting to CNY 2,333,863.12[12] - Cash inflow from operating activities for Q1 2024 was CNY 43,378,361.61, an increase from CNY 41,619,511.27 in Q1 2023, representing a growth of approximately 4.23%[40] - Net cash flow from operating activities for Q1 2024 was CNY 2,333,863.12, down from CNY 3,514,839.27 in Q1 2023, indicating a decline of about 33.6%[40] - Total cash outflow from investing activities in Q1 2024 was CNY 15,379,104.78, compared to CNY 37,439,603.20 in Q1 2023, showing a decrease of approximately 58.9%[42] - Net cash flow from investing activities for Q1 2024 was -CNY 11,377,444.78, an improvement from -CNY 33,286,828.31 in Q1 2023[42] - Cash outflow from financing activities in Q1 2024 was CNY 3,649,111.77, up from CNY 2,800,863.42 in Q1 2023, reflecting an increase of about 30.3%[42] Assets and Liabilities - Total assets as of March 31, 2024, were CNY 420,331,875.08, a decrease of 0.40% compared to the end of the previous year[12] - The company's total liabilities to total assets ratio was 17.87% as of March 31, 2024, compared to 17.67% at the end of the previous year[12] - Current liabilities increased from 37,364,195.04 to 40,899,455.58, an increase of about 13.5%[31] - Non-current liabilities decreased from 37,224,068.20 to 34,205,832.82, a reduction of approximately 8.2%[32] - Total liabilities increased slightly from 74,588,263.24 to 75,105,288.40, an increase of about 0.7%[32] - Shareholders' equity decreased from 347,441,396.29 to 345,226,586.68, a decline of approximately 0.6%[32] Research and Development - Research and development expenses increased by 58.80% year-on-year, totaling CNY 5,639,953.34, due to an increase in R&D projects[14] - Research and development expenses rose significantly to ¥5,639,953.34, a 58.66% increase from ¥3,551,660.42 in the same period last year[36] Shareholder Information - Total equity held by shareholders with over 5% ownership is 82.75%[22] - The largest shareholder, China Textile Science Research Institute Co., Ltd., holds 58.54% of shares[21] - The total number of ordinary shareholders is 6,150[20] Other Income and Expenses - Other income rose significantly by 252.22% year-on-year, reaching CNY 2,413,219.16, primarily due to increased government subsidies[14] - Other income increased to ¥2,413,219.16 in Q1 2024, compared to ¥685,140.74 in Q1 2023, reflecting a growth of 252.06%[36] - The company experienced a credit impairment loss of ¥550,070.41 in Q1 2024, compared to a gain of ¥756,238.63 in Q1 2023[37] Miscellaneous - The company has not reported any significant legal disputes or external guarantees during the reporting period[26] - There were no changes in accounting policies or errors corrected during the reporting period[19] - Total current assets as of March 31, 2024, amounted to CNY 272,666,811.79, a decrease from CNY 278,765,451.43 at the end of 2023[30] - Cash and cash equivalents were CNY 213,258,446.15, down from CNY 224,451,139.58[30] - Accounts receivable increased to CNY 50,095,814.67 from CNY 46,905,981.92[30] - Inventory decreased to CNY 2,939,689.23 from CNY 3,373,360.41[30] - The weighted average return on equity based on net profit attributable to shareholders was -0.36% for the first quarter of 2024, compared to 0.23% in the same period last year[12]

Achievements and Certifications - In January 2023, Fujian Chinatesta successfully passed the national high-tech enterprise certification[4]. - In May 2023, Chinatesta and its subsidiaries became the first batch of testing and certification laboratories included in the customs import clothing inspection recognition list[4]. - In August 2023, Chinatesta officially initiated six national standard samples[5]. - In September 2023, two international standards drafted by Chinatesta were officially released[5]. - In December 2023, Chinatesta obtained three system certification qualifications[5]. - The company was awarded the "2022 China Standard Innovation Contribution Award" for the mandatory national standard GB 31701-2015 in March 2023[4]. - Chinatesta's Jiangxi company received CNAS accreditation approval in September 2023[5]. - The company has been recognized as a high-tech enterprise, which supports its credibility and market position[41]. Financial Performance - The company's operating revenue for 2023 was CNY 191,727,433.84, representing a year-over-year increase of 2.74% compared to CNY 186,605,173.13 in 2022[27]. - The net profit attributable to shareholders decreased by 7.66% to CNY 33,147,743.71 in 2023 from CNY 35,899,041.77 in 2022[27]. - The gross profit margin for 2023 was 47.86%, down from 51.06% in 2022[27]. - Total assets increased by 9.84% to CNY 422,029,659.53 at the end of 2023, compared to CNY 384,205,746.57 at the end of 2022[29]. - Total liabilities rose significantly by 48.59% to CNY 74,588,263.24 in 2023 from CNY 50,198,062.40 in 2022[29]. - The cash flow from operating activities for 2023 was CNY 64,069,750.14, a substantial increase of 76.45% from CNY 36,310,429.15 in 2022[30]. - The weighted average return on equity (ROE) based on net profit attributable to shareholders was 7.13% in 2023, down from 9.83% in 2022[27]. - The basic earnings per share decreased by 14.29% to CNY 0.36 in 2023 from CNY 0.42 in 2022[27]. - The company achieved operating revenue of 191.73 million yuan, a year-on-year increase of 2.74%, and a net profit attributable to shareholders of 33.15 million yuan, a decrease of 7.66% compared to the previous year[42]. Research and Development - The company invested 9.45% of its revenue in R&D, an increase of 1.85 percentage points compared to the previous year, to enhance its technological capabilities[43]. - The company is currently implementing several projects, including a new testing technology R&D center and a digital management platform, to improve operational efficiency and expand capacity[43]. - The company reported a research and development expenditure of ¥18,124,319.43, representing a 27.75% increase compared to the previous period[84]. - R&D expenditure accounted for 9.45% of operating revenue, up from 7.60% in the previous period, indicating a significant increase in investment in innovation[84]. - Key R&D projects included the calibration research for medical textile testing instruments, addressing the surge in demand for masks and protective clothing due to COVID-19[184]. - The company developed a new method for testing harmful substances in textiles and leather, improving detection capabilities[185]. - The company has established a strong team of experienced professionals in textile standards and certification, providing robust technical support for future development[186]. Market and Industry Trends - The third-party testing market is expected to grow due to increasing consumer demand for quality assurance and safety in products[46]. - The inspection and testing industry in China achieved a revenue of 427.58 billion yuan in 2022, representing a growth of 4.54% compared to 2021[106]. - The textile and apparel retail sales in China increased by 12.9% year-on-year in 2023, showing a significant recovery in the market[111]. - The online retail sales of clothing and related products grew by 10.8% year-on-year in 2023, indicating a rebound in consumer spending[111]. - The inspection and testing industry is expected to benefit from government policies aimed at promoting high-quality development and innovation[110]. Corporate Governance and Management - The company has established a new corporate governance system during the year[192]. - The board of directors held 7 meetings during the reporting period, addressing 14 significant proposals[199]. - The company implemented a cumulative voting system for the election of directors and supervisors, ensuring protection of minority shareholders' rights[195]. - The company has not identified any major defects in its internal management systems this year[192]. - The company has established a responsibility accountability system for significant errors in the annual report[192]. - The company has a dedicated investor hotline and website to facilitate communication with investors[195]. - The company is focusing on enhancing its financial management capabilities with the appointment of experienced professionals[166]. Social Responsibility and Environmental Initiatives - The company actively participated in poverty alleviation efforts, purchasing over ¥60,000 worth of agricultural products from designated poverty alleviation areas[100]. - The company has implemented a comprehensive environmental protection strategy, achieving a 100% signing rate for energy-saving and environmental protection responsibility agreements[105]. - The company organized over 20 educational and promotional events to enhance industry knowledge and promote sustainable development[103]. - The company has introduced multiple product certification projects, including "green fibers" and "biodegradable products," to support the green development of the textile industry[104]. Shareholder Information - The company completed the cancellation of 35,000 repurchased shares, reducing the total share capital to 92,402,108 shares as of January 19, 2024[24]. - The company plans to hold its first extraordinary general meeting of 2024 on February 22 to discuss share repurchase and capital changes[24]. - The largest shareholder, China Textile Science Research Institute Co., Ltd., holds 54,000,000 shares, representing 58.42% of total shares[136]. - The total number of shareholders holding ordinary shares is 4,648[132]. - The company has a cash dividend policy that stipulates a minimum distribution of 10% of the annual distributable profit when conditions are met[150]. - The annual distribution plan includes a cash dividend of CNY 1.799611 per 10 shares, with no stock dividends or capital increases proposed[155].

2023 中纺标检验认证股份有限公司 chinatesta textile testing & certification services STNatio 前篇 | 报告说明 | 02 | | --- | --- | | 总经理致辞 | 03 | | 公司可持续发展理念 | 05 | | 走进中纺标 | 06 | | 2023年度大事记 | 09 | | 2023年度荣誉墙 | 11 | 01 夯实合规治理 | 1.1 推动稳健治理 | 14 | | --- | --- | | 1.2 强化合规运营 | 20 | | 1.3 严守商业道德 | 22 | 02 打造优质服务 | 专题篇: | | | --- | --- | | 数智赋能 提升核心竞争力 | 24 | | 2.1 构建品质服务 | 31 | | 2.2 强化研发创新 | 32 | | 2.3 践行阳光采购 | 34 | | 2.4 遵循责任营销 | 35 | 03 加强绿色运营 | 3.1 把握双碳机遇 | 38 | | --- | --- | | 3.2 维护安全与环境管理 | 40 | | 3.3 严控排放风险 | 42 | 04 呵护员工 ...